Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.

Faxon, D P

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. [electronic resource] - Journal of the American College of Cardiology Feb 1995 - 362-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0735-1097

10.1016/0735-1097(94)00368-z doi


Angioplasty, Balloon, Coronary
Aspirin--therapeutic use
Cilazapril--administration & dosage
Coronary Angiography
Coronary Disease--diagnostic imaging
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Linear Models
Male
Middle Aged
Recurrence
Risk Factors
Time Factors
Treatment Outcome